DennisLCooperMD

Oncology • Bronx, NY

Hematologic Oncology

Professor of Medicine, Yale University

Join to view full profile

Dr. Cooper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cooper's full profile

Already have an account?

Office
111 E 210th St
Bronx, NY 10467
Phone+1 718-920-4826

Fax+1 732-235-8094

Education & Training

UPMC Medical EducationResidency, Internal Medicine, 1982 - 1983
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
Rush Medical College of Rush University Medical CenterClass of 1979
Yale-New Haven Medical CenterFellowship, Medical Oncology

Certifications & Licensure

NY State Medical License 2022 - 2026
CT State Medical License 1981 - 2025
NJ State Medical License 2015 - 2023
PA State Medical License 1982 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

616 citations
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Ivana N. Micallef, Patrick J. Stiff
Blood. 2009-06-04
274 citations
Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
E Salloum, Dennis L. Cooper, G. Howe, Jill Lacy, Giovanni Tallini
Journal of Clinical Oncology. 1996-06-01
57 citations
Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification ...
Benjamin Smith, Earl J. Glusac, Jennifer M. McNiff, Grace L. Smith, Peter Heald
Journal of Clinical Oncology. 2004-02-15

Abstracts/Posters

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up
Dennis Cooper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019